Bespoke Extracts (BSPK) Shareholder's Equity Growth (1y) (2012 - 2025)
Bespoke Extracts (BSPK) Shareholder's Equity Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.42% |
| Jun 30, 2025 | -16.90% |
| Mar 31, 2025 | -18.33% |
| Dec 31, 2024 | -21.30% |
| Sep 30, 2024 | -49.92% |
| Jun 30, 2024 | -60.95% |
| Mar 31, 2024 | -103.30% |
| Dec 31, 2023 | -156.59% |
| Sep 30, 2023 | -200.26% |
| Jun 30, 2023 | -173.74% |
| Mar 31, 2023 | -148.84% |
| Nov 30, 2021 | 78.20% |
| Aug 31, 2021 | 18.58% |
| May 31, 2021 | 45.08% |
| Feb 28, 2021 | 111.92% |
| Nov 30, 2020 | -1,132.76% |
| Aug 31, 2020 | -1,523.88% |
| May 31, 2020 | -465.78% |
| Feb 29, 2020 | 62.34% |
| Nov 30, 2019 | 94.04% |